Home

Home

Back to bed safely

Patients can be unpredictable and, if they leave their beds, some might come to harm if their movements go unnoticed. WeSpot SecNurse, a new monitoring sysem produced by the Dutch firm Secumatic, transmits an alarm to an existing nurse call system when its sensor detects a patient’s departure from bed.

article image
In addition, according to the level of care an individual patient needs, the system can be set to send an alarm only after a specified time lapse. For example, if a patient is capable mentally and physically to go to the toilet alone, the alarm could be set to go off only if they do not return to bed after ten minutes.

No video images are provided. The camera technique in the SecNurse is used to monitor and interpret within the sensor. The only output contacts are two simple relays.

Secumatic also points out that the system not only provides privacy for patients, but reduces false alarms and is cost-efficient and, the firm adds, it is, ‘…easy to install, can be placed everywhere (both permanent and ambulant), is easy to integrate in each nurse call system, maintenance free, hygienic and does not need physical contact with the patient.’

Details: info@secumatic.nl

This article was published on 12/27/2006

Search

 

Service

Company News

Carestream: technical infrastructure for EU funded R-bay project

Carestream Health is a major technical infrastructure provider to the EU-funded R-Bay validation project, which aims to address the uneven spread of radiologists across member states. CARESTREAM Radiology and Information Management Solutions are driving the initial test platform for the project by facilitating remote reporting of images from hospitals in Denmark, Finland and Czech Republic by clinical providers in Estonia, Lithuania and the Netherlands.

Insulin in oral capsules

At the international congress on diabetes in September, Oramed Pharmaceuticals, Inc. introduced its oral insulin capsules that might in the future replace injections patients currently have to face. Last week Oramed announced the agreement with ETI Karle Clinical Pvt. Ltd. to conduct phase 2B clinical trials for its oral insulin capsules.

Products redesigned to help patients simplify life with diabetes

Bayer HealthCare Diabetes Care unveiled the new
CONTOUR® blood glucose meter with enhanced testing features at the 44th Annual Meeting of the European Association for the Study of Diabetes in Rome, Italy.